1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Emerging Global Leader Award (K43 Independent Clinical Trial Required) is sponsored by Fogarty International Center, National Institutes of Health (NIH). This award provides research support and protected time to a research scientist from a low- or middle-income country (LMIC) who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Research scientists from LMIC institutions holding an academic junior faculty position or research scientist appointment at an LMIC academic or research institution. Confirm the full requirements in the official notice before applying.
Applications for Emerging Global Leader Award (K43 Independent Clinical Trial Required) are due December 3, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Emerging Global Leader Award (K43 Independent Clinical Trial Required) is funded by Fogarty International Center, National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Ethical, Legal, and Social Implications (ELSI) Research (R03 Clinical Trial Not Allowed) is sponsored by Fogarty International Center, National Institutes of Health (NIH). Fogarty is interested in supporting research on ethical issues related to human genome research relevant to low- and middle-income countries (LMICs), particularly studies conducted by investigators in these countries.
Ethical, Legal, and Social Implications (ELSI) Research (R21 Clinical Trial Optional) is sponsored by Fogarty International Center, National Institutes of Health (NIH). Fogarty is interested in supporting research on ethical issues related to human genome research relevant to low- and middle-income countries (LMICs), particularly studies conducted by investigators in these countries.
Ethical, Legal, and Social Implications (ELSI) Research (R01 Clinical Trial Not Allowed) is sponsored by Fogarty International Center, National Institutes of Health (NIH). Fogarty is interested in supporting research on ethical issues related to human genome research relevant to low- and middle-income countries (LMICs), particularly studies conducted by investigators in these countries.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article